Latest Insider Transactions at Regulus Therapeutics Inc. (RGLS)
This section provides a real-time view of insider transactions for Regulus Therapeutics Inc. (RGLS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Regulus Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Regulus Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 04
2020
|
Scott D Sandell > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,398,602
+40.54%
|
$0
$0.62 P/Share
|
|
Dec 04
2020
|
Peter W. Sonsini > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,398,602
+40.54%
|
$0
$0.62 P/Share
|
|
Dec 04
2020
|
Paul Edward Walker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,398,602
+40.54%
|
$0
$0.62 P/Share
|
|
Nov 16
2020
|
Joseph P Hagan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,094
-2.74%
|
$0
$0.52 P/Share
|
|
Nov 16
2020
|
Christopher Ray Aker Sr. VP & General Counsel |
SELL
Open market or private sale
|
Direct |
876
-3.29%
|
$0
$0.52 P/Share
|
|
Nov 12
2014
|
Astrazeneca PLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,000,000
-32.0%
|
$34,000,000
$17.0 P/Share
|
|
Feb 04
2014
|
Sanofi > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,303,780
+20.51%
|
$9,126,460
$7.67 P/Share
|